Anonymous ID: 2b8969 Dec. 6, 2023, 5:30 a.m. No.20033745   🗄️.is đź”—kun   >>3747 >>3754 >>3757

What We Know About Elon Musk's Political Views

Story by Maxine Page •

1h

 

https://www.msn.com/en-us/autos/news/what-we-know-about-elon-musk-s-political-views/ar-AA1l5dCQ?ocid=msedgntp&pc=HCTS&cvid=e696ac5ce6324147af151feda0a44f91&ei=12

Anonymous ID: 2b8969 Dec. 6, 2023, 5:31 a.m. No.20033747   🗄️.is đź”—kun   >>3751

>>20033745

 

"In April 2020, Musk ranted against COVID-19 lockdown measures, claiming they were fascist and unconstitutional. "I would call it forcibly imprisoning people in their homes against all their constitutional rights," Musk told Tesla investors (via NPR). He played down the effects of the virus and persistently called for lockdown to be lifted. "Free America now," Musk posted."

Anonymous ID: 2b8969 Dec. 6, 2023, 5:35 a.m. No.20033763   🗄️.is đź”—kun   >>3933 >>4123

>>20033751

 

“Could we tolerate a national system in which certain people on the basis of a biomarker are segregated?”

 

https://threadreaderapp.com/thread/1729913580466626893.html

 

VIVEK

 

In April 2020, as the U.S. went into lockdown, Ramaswamy said he would be open to that kind of system to determine who could “go back to normal life.” He described it as an “inequity,” but concluded that “everyone stands to benefit from it.” Ramaswamy made the comments during an episode of Rockefeller Client Insights, the podcast of Rockefeller Capital Management.

 

A concept like that is sharply at odds with the image of the civil libertarian he has cultivated during the primary. It also raises questions about his anti-establishment bona fides.

 

During the podcast, Ramaswamy talked about different aspects of the coronavirus outbreak with Gregory J. Fleming, the president and CEO of Rockefeller Capital Management. Fleming asked him what a “path to normalcy” might look like, given what he described as a “potentially extended timeline” for the rollout of vaccines and treatments. The country was then more than 15 days into “15 days to slow the spread.”

 

“One path to normalcy and a path that I’d like to see further progress made on is broad rollout of our antibody tests,” Ramaswamy said. He corrected himself and continued:

 

“It’s not our company; I’m saying, as a society, rolling out the antibody tests such that we actually get our arms around what portion of the population is already immune through exposures that they may not have even known that they had. It might be 10 percent, it might be 20 percent, we might discover that it is some higher number. Those people are gonna be able to get back to work pretty quickly, get back to normal life because effectively they have the immunity badge, they have a badge in the form of their antibodies that protect them best we know from reinfection.

 

On the flip side, you then have the people who don’t have immunity, and the question is those who are negative on the antibody tests, what happens with them? Now, this has been—I’ve had discussions in the last few days with policymakers, a couple of people in Congress, one U.S. Senator, and I think this is not lost on folks. But I think one early topic that’s come up is, could we tolerate a national system in which certain people on the basis of a biomarker are segregated? To say you can’t go back to normal life, where certain people get a head start. Is that an inequity we would tolerate? I personally think that it is better than the status quo if we can send 10 or 20 percent of the people back on the basis of having immunity that’s proven on the basis of a lab-based result that’s now available. That’s a good thing, and everyone stands to benefit from it.”

Anonymous ID: 2b8969 Dec. 6, 2023, 6:22 a.m. No.20033933   🗄️.is đź”—kun   >>3938 >>3948 >>3960 >>4079

>>20033763

 

More: https://threadreaderapp.com/thread/1730024852851962166.html

 

Pedro L. Gonzalez

Pedro L. Gonzalez

@emeriticus

Nov 30

 

Vivek is responding to my reporting. He isn’t being honest. He didn’t just say something “stupid” on a podcast. He sent members of Congress a memo advocating against lifting lockdowns and for creating a national registry. A company he created pitched the idea to the FDA and worked with the federal government on it.

 

Here’s a timeline:

 

-February 2020: Datavant, a healthcare data company created by Vivek, recruits George W. Bush-Era FDA Commissioner Andrew von Eschenbach.

 

-March 2020: Datavant begins spearheading a registry of COVID-19 patients by pooling medical records from across the country (WSJ).

 

-April 3, 2020: Vivek says on the Rockefeller Client Insights podcast that he supports a system where people would be “segregated” under a national testing regime.

 

-April 8, 2020: Datavant is in touch with the FDA about a “proposed registry” that “would aim to include every patient who has been tested for COVID-19” (WSJ).

 

It was around this time that Vivek circulated the memo I obtained to members of Congress in which he argued against lifting lockdowns and for implementing universal testing to determine who could go back to life. He concluded by proposing a “public-private” partnership, which is what his company Datavant pitched to the federal government.

 

-November 2020: Vivek’s company announced that it was collaborating on gathering patient data with the National COVID Cohort Collaborative, which is funded by the National Institutes of Health’s National Center for Advancing Translational Sciences.

 

Vivek didn’t just support lockdowns—he tried to profit from it while collaborating with the very “regime” he claims to oppose. Then he tried to bury it, like he tried to bury details about his background by paying a Wikipedia editor to sanitize his biography weeks before declaring his candidacy.